Loading company…
Relmada Therapeutics develops oral medications for chronic pain and other disorders.
Founded in 2004, Relmada Therapeutics is a clinical-stage specialty pharmaceutical company developing oral medications for chronic pain associated with depression, central nervous system disorders, and ophthalmic disorders. It is based in New York, US, and is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in